Low SIAH2 expression in breast cancer is associated with resistance to endocrine therapy

被引：0
|
作者：
Jansen, M. P. H. M. [1 ]
Dorssers, L. C. J. [1 ]
Ritstier, K. [1 ]
Foekens, J. A. [1 ]
van Staveren, I. L. [1 ]
Helleman, J. [1 ]
Look, M. P. [1 ]
Sieuwerts, A. M. [1 ]
Klijn, J. G. M. [1 ]
Berns, R. M. J. J. [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70764-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [21] Pathways to Endocrine Therapy Resistance in Breast Cancer
    Haque, Md Moquitul
    Desai, Kartiki, V
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [22] Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression
    Liu, Qiangqiang
    Luo, Qian
    Feng, Jianyu
    Zhao, Yanping
    Ma, Biao
    Cheng, Hongcheng
    Zhao, Tian
    Lei, Hong
    Mu, Chenglong
    Chen, Linbo
    Meng, Yuanyuan
    Zhang, Jiaojiao
    Long, Yijia
    Su, Jingyi
    Chen, Guo
    Li, Yanjun
    Hu, Gang
    Liao, Xudong
    Chen, Quan
    Zhu, Yushan
    ELIFE, 2022, 11
  • [23] Human Siah2 regulates protein expression of repp86
    Heidebrecht, HJ
    Szczepanowski, M
    Parwaresch, R
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2005, 84 : 24 - 24
  • [24] The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression
    Chan, Peter
    Moeller, Andreas
    Liu, Mira C. P.
    Sceneay, Jaclyn E.
    Wong, Christina S. F.
    Waddell, Nic
    Huang, Katie T.
    Dobrovic, Alexander
    Millar, Ewan K. A.
    O'Toole, Sandra A.
    McNeil, Catriona M.
    Sutherland, Robert L.
    Bowtell, David D.
    Fox, Stephen B.
    BREAST CANCER RESEARCH, 2011, 13 (01):
  • [25] The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression
    Peter Chan
    Andreas Möller
    Mira CP Liu
    Jaclyn E Sceneay
    Christina SF Wong
    Nic Waddell
    Katie T Huang
    Alexander Dobrovic
    Ewan KA Millar
    Sandra A O'Toole
    Catriona M McNeil
    Robert L Sutherland
    David D Bowtell
    Stephen B Fox
    Breast Cancer Research, 13
  • [26] The Ubiquitin Ligase Siah2 Controls PPARγ and β-Catenin Expression During Adipogenesis
    Kilroy, Gail
    Kirk-Ballard, Heather
    Carter, Lauren
    Floyd, Elizabeth
    DIABETES, 2012, 61 : A430 - A431
  • [27] Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma
    Gao, Ya
    Liu, Yunduo
    Meng, Fanling
    Shang, Pan
    Wang, Shuxiang
    Zhang, Yu
    Sun, Yuqi
    Wang, Yuping
    Wang, Jing
    Chen, Xiuwei
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (01) : 114 - 119
  • [28] Overcoming endocrine resistance in neoadjuvant endocrine therapy for early breast cancer
    Jackisch, Christian
    LANCET ONCOLOGY, 2019, 20 (09): : 1185 - 1187
  • [29] BCAR4 Expression as a Predictive Biomarker for Endocrine Therapy Resistance in Breast Cancer
    Liao, Muheng
    Webster, Jace
    Coonrod, Emily M.
    Weilbaecher, Katherine N.
    Maher, Christopher A.
    White, Nicole M.
    CLINICAL BREAST CANCER, 2024, 24 (04) : 368 - 375.e2
  • [30] Predicting response/resistance to endocrine therapy for breast cancer
    Miller, WR
    Anderson, TJ
    Evans, D
    Krause, A
    Dixon, JM
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S5 - S6
12345